111 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
Rank Status Study
21 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
Condition: Atrial Fibrillation
Interventions: Drug: Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban;   Drug: Vitamin K antagonist: warfarin, fluindione, acenocoumarol
22 Recruiting Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
Conditions: Angina, Stable;   Angina, Unstable;   Anticoagulants
Interventions: Device: COBRA PzF;   Device: DES
23 Recruiting Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
Condition: Hematoma
Interventions: Drug: Dabigatran;   Drug: Rivaroxaban;   Drug: Apixaban
24 Unknown  Determination of Residual Anticoagulatory Effects of Fondaparinux
Condition: Anticoagulant Prophylaxis/Therapy
Intervention:
25 Recruiting Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
26 Recruiting Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
Condition: DOAC Eligible Subjects
Intervention: Device: TEG6s DOAC Cartridge
27 Recruiting Register for New Oral Anticoagulants
Condition: Anticoagulation Treatment
Intervention:
28 Not yet recruiting Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Conditions: Cancer;   Venous Thromboembolism;   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Blood Clot;   VTE
Interventions: Drug: Rivaroxaban;   Drug: Apixaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Warfarin;   Drug: Dalteparin;   Drug: Enoxaparin;   Drug: Fondaparinux
29 Recruiting Sequential Expansion of Comparative Effectiveness of Anticoagulants
Condition: Atrial Fibrillation
Intervention:
30 Unknown  Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent
Condition: Healthy
Intervention: Drug: Indobufen
31 Recruiting Reversal of Dabigatran Anticoagulant Effect With Idarucizumab
Condition: Hemorrhage
Intervention: Drug: idarucizumab
32 Recruiting Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
Condition: Benign Prostatic Hyperplasia
Intervention:
33 Not yet recruiting Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
Condition: Atrial High Rate Episodes
Interventions: Drug: Edoxaban;   Drug: ASA
34 Recruiting Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes (HECICS)
Condition: Intra Operative Bleeding, Blood Salvage
Interventions: Drug: ACD-A;   Drug: Heparin
35 Recruiting Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
Intervention:
36 Recruiting What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Conditions: Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.
37 Not yet recruiting COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials
Conditions: Stable Angina;   Unstable Angina;   STEMI;   NSTEMI;   Coronary Disease
Interventions: Device: COMBO-Stent;   Drug: Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran;   Device: Any drug eluting stent oder bare metal sent;   Drug: ASA, Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran
38 Recruiting Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate
Conditions: Benign Prostatic Hyperplasia;   Prostate Cancer
Intervention:
39 Not yet recruiting Treatment of Intracerebral Hemorrhage in Patients on Non-vitamin K Antagonist
Condition: Intracerebral Hemorrhage
Interventions: Drug: Tranexamic acid;   Drug: Saline 0.9%
40 Unknown  D-Dimer Guided Oral Anticoagulant Treatment (OAT)
Condition: Deep Venous Thrombosis
Interventions: Drug: Phenprocoumon;   Drug: Warfarin-Natrium

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years